Ascentage Pharma Group International (NASDAQ:AAPG – Get Free Report) shares reached a new 52-week high on Wednesday . The company traded as high as $19.37 and last traded at $19.37, with a volume of 69151 shares. The stock had previously closed at $18.51.
Ascentage Pharma Group International Trading Up 4.6 %
Ascentage Pharma Group International Company Profile
Ascentage Pharma Group International Co, Ltd. is a clinical-stage biotechnology company. It engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases. The company was founded by Da Jun Yang, Wang Shao Meng and Ming Guo in May 2009 and is headquartered in Suzhou, China.
Further Reading
- Five stocks we like better than Ascentage Pharma Group International
- Airline Stocks – Top Airline Stocks to Buy Now
- Nebius Group: NVIDIA’s Investment Sparks All-Time Highs
- How to Capture the Benefits of Dividend Increases
- SoFi Stock Rallying Strong in the Last 5 Days—What’s Driving It?
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Intel Surges on M&A Talks: Rally Beginning or Just a Headfake?
Receive News & Ratings for Ascentage Pharma Group International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ascentage Pharma Group International and related companies with MarketBeat.com's FREE daily email newsletter.
